Syngene International Ltd
NSE:SYNGENE

Watchlist Manager
Syngene International Ltd Logo
Syngene International Ltd
NSE:SYNGENE
Watchlist
Price: 847.2 INR 0.55% Market Closed
Market Cap: 340B INR
Have any thoughts about
Syngene International Ltd?
Write Note
Section:
 

Relative Value

The Relative Value of one SYNGENE stock under the Base Case scenario is 1 003.14 INR. Compared to the current market price of 847.2 INR, Syngene International Ltd is Undervalued by 16%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

SYNGENE Relative Value
Base Case
1 003.14 INR
Undervaluation 16%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

9.8
P/S
P/S
Price to Sales
9.8
vs History
11
vs Industry
19
Median 3Y
8.7
Median 5Y
9.1
Industry
4.1
Forward
8.8
More Details
70.5
P/E
P/E
Price to Earnings
70.5
vs History
1
vs Industry
8
Median 3Y
58.5
Median 5Y
57.4
Industry
32.7
Forward
63.2
More Details
35.4
P/OCF
P/OCF
Price to OCF
35.4
vs History
23
vs Industry
19
Median 3Y
35.6
Median 5Y
33.6
Industry
22.1
More Details
589.1
P/FCFE
P/FCFE
Price to FCFE
589.1
vs History
20
vs Industry
100
Median 3Y
299
Median 5Y
131
Industry
33.6
More Details
7.7
P/B
P/B
Price to Book Value
7.7
vs History
26
vs Industry
12
Median 3Y
7.4
Median 5Y
7.6
Industry
2.6
More Details
9.7
EV/S
EV/S
Enterprise Value to Sales
9.7
vs History
11
vs Industry
19
Median 3Y
8.6
Median 5Y
8.9
Industry
3.9
Forward
8.7
More Details
13.2
EV/GP
EV/GP
Enterprise Value to Gross Profit
13.2
vs History
7
vs Industry
29
Median 3Y
12
Median 5Y
12.1
Industry
8.6
More Details
33.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
33.9
vs History
6
vs Industry
15
Median 3Y
29.3
Median 5Y
30
Industry
18.5
Forward
29.5
More Details
60.9
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
60.9
vs History
1
vs Industry
8
Median 3Y
47.8
Median 5Y
49.3
Industry
23.7
Forward
47.7
More Details
34.9
EV/OCF
EV/OCF
Enterprise Value to OCF
34.9
vs History
22
vs Industry
19
Median 3Y
35.1
Median 5Y
32.8
Industry
21.4
More Details
70.6
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
70.6
vs History
77
vs Industry
9
Median 3Y
98.3
Median 5Y
102.5
Industry
28.8
More Details
6.9
EV/IC
EV/IC
Enterprise Value to IC
6.9
vs History
12
vs Industry
14
Median 3Y
6.4
Median 5Y
6.4
Industry
2.4
More Details

Multiples Across Competitors

SYNGENE Competitors Multiples
Syngene International Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IN
Syngene International Ltd
NSE:SYNGENE
339.9B INR 9.8 70.5 33.9 60.9
US
PerkinElmer Inc
LSE:0KHE
1.2T USD 448.2 4 796.2 1 513.6 3 225.5
US
Thermo Fisher Scientific Inc
NYSE:TMO
200.4B USD 4.7 32.7 21.2 30.4
US
Danaher Corp
NYSE:DHR
165.4B USD 7.8 42.5 26.7 40.1
KR
Samsung Biologics Co Ltd
KRX:207940
66.8T KRW 15.3 63.4 34.3 49.4
CH
Lonza Group AG
SIX:LONN
38.4B CHF 5.7 67 45.3 45.3
US
Agilent Technologies Inc
NYSE:A
38.5B USD 5.9 29.9 22.3 25.9
US
IQVIA Holdings Inc
NYSE:IQV
35.9B USD 2.4 25.7 14.1 21.5
US
Mettler-Toledo International Inc
NYSE:MTD
26.8B USD 7.1 33.7 24.1 26.9
US
West Pharmaceutical Services Inc
NYSE:WST
24.1B USD 8.3 47.9 32.3 40.6
CN
WuXi AppTec Co Ltd
SSE:603259
164.4B CNY 4.3 20.4 14.8 14.8

See Also

Summary
SYNGENE intrinsic value, competitors valuation, and company profile.
DCF Valuation
SYNGENE stock valuation using Discount Cash Flow valuation method.
Relative Valuation
SYNGENE stock valuation using valuation multiples.
Wall Street Estimates
SYNGENE price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
SYNGENE stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Back to Top
ALPHA SPREAD
Follow us
Join more than 210,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.